The global “Bio-identicalHormones Market” research report includes qualitative and quantitativedata on industry growth rates, market segmentation, Bioidentical Hormonesmarket size, demand, and revenue. The study examines current Bio-identicalHormones market trends that are projected to have an impact on the industry'sfuture prospects. The paper goes on to look into and evaluate the current stateof the ever-changing business sector, as well as the current and prospectiveeffects of COVID-19 on the market.
The pre- and post-COVID-19 consequences are discussed in theGlobal Bio-identical Hormones Market research. The paper goes through thepositives as well as the drawbacks in terms of finance and market expansionthat occurred during the crisis. Despite a severe economic downturn, theBioidentical Hormones Market has recovered by implementing new tactics anddeveloping new capabilities. On both a regional and global scale, the markethas begun to look for other funding sources and business models in order tostay afloat.
Growing screening for hormonal deficit, an ageingpopulation, and increased knowledge and income of women are all important keydrivers for the worldwide bioidentical hormones market. Bioidentical hormonesare used to alleviate the symptoms of menopause and the issues that come withit. Fatigue, hot flashes, mood swings, nocturnal sweats, vaginal dryness,weight gain, and other symptoms and consequences are examples. The absence ofapproval for bioidentical hormones by the US Food and Drug Administration isthe most significant obstacle that could limit market expansion (FDA). Thepurity and safety of bioidentical hormones market cannot be assured due to alack of authorisation.
Because of widespread pharmaceutical use, rapid absorptionof new treatments in the United States, and high healthcare spending, theAmericas account for the largest part of the market. The majority of thisregion's research companies are headquartered in industrialised countries likethe United States, with a few in Canada. North America is the larger market inSouth America due to revenue from the United States and Canada. Argentina andBrazil are the strongest economies in South America, and they have thepotential to become key country-specific markets in the future. North Americais a larger regional market segment than South America due to the availabilityof advanced medical facilities and revenue generated in the United States.
Bio-identical Hormones Market - Size, Share, Outlook, andOpportunities, by Product Type (Estrogen, Progesterone, and Testosterone),Dosage Form (Tablets and Capsules, Creams and Gels, Injectable, Patches andImplants, and Others), End User (Hospitals, Clinics, Academics and ResearchInstitutes, and Others), and Region (North America, Latin America, Europe, AsiaPacific, Middle East, and
With increasing age, hormone levels such as oestrogen,progesterone, and testosterone in the body decrease, causing menopausalsymptoms in women such as hot flashes, weight gain, and vaginal pain due tosexual intercourse, as well as vaginal dryness, night sweats, and mood swings.Low testosterone levels in men can lead to erectile dysfunction and a loss ofbone density. Bio-identical hormones are used to treat men and women who havelow or imbalanced natural hormone levels. Bio-identical hormones are synthetichormones that work as a replacement for natural hormones and raise hormonallevels in the body.
Over the forecast period, factors such as an ageing populationand females in the menopausal age range are likely to promote the growth of thebio-identical hormones market. According to an article published in theNational Center for Biotechnology Information (NCBI) in November 2019, around1.3 million women in the United States undergo menopause each year, withapproximately 75% of women experiencing vasomotor symptoms like hot flashes,palpitations, and nocturnal sweating.
On the basis ofproduct type, the global bio-identical hormones market is segmentedinto:
· Estrogen
· Progesterone
· Testosterone
On the basis ofdosage form, the global bio-identical hormones market is segmentedinto:
· Tablets and Capsules
· Creams and Gels
· Injectable
· Patches and implants
· Others
